Q16R (p.Gln16Arg) variant of ABL2 (Tyrosine-protein kinase ABL2)
Q16R (p.Gln16Arg) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data.
Q16R (p.Gln16Arg) variant details
- p.Gln16Arg
- TOPMed rs1663420207
- Missense
- Variant Prioritization Score for Impact Estimate 0.339
- REVEL 0.12
- CADD 21.50
- PolyPhen-2 0.03
- SIFT 0.08
- Population evidence available